Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513129 | SCV000608673 | uncertain significance | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000513129 | SCV000614963 | uncertain significance | not provided | 2021-08-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001275193 | SCV002026522 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002527402 | SCV003466272 | likely benign | Spastic paraplegia | 2024-10-22 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001275193 | SCV003820634 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2021-02-09 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV001275193 | SCV004809632 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2024-04-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001275193 | SCV001460057 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2020-01-12 | no assertion criteria provided | clinical testing |